HomeSPH • WSE
add
Sopharma AD
Previous close
zł 7.02
Day range
zł 7.42 - zł 7.50
Year range
zł 4.00 - zł 16.00
Market cap
918.30M EUR
Avg Volume
761.00
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (BGN) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 710.03M | 19.04% |
Operating expense | 151.56M | 35.70% |
Net income | 22.74M | 91.66% |
Net profit margin | 3.20 | 60.80% |
Earnings per share | — | — |
EBITDA | 30.00M | 80.90% |
Effective tax rate | 2.82% | — |
Balance Sheet
Total assets
Total liabilities
| (BGN) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 71.60M | 100.58% |
Total assets | 2.08B | 15.78% |
Total liabilities | 1.10B | 15.18% |
Total equity | 981.81M | — |
Shares outstanding | 525.53M | — |
Price to book | 3.88 | — |
Return on assets | 2.51% | — |
Return on capital | 3.20% | — |
Cash Flow
Net change in cash
| (BGN) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 22.74M | 91.66% |
Cash from operations | 54.35M | -0.13% |
Cash from investing | -4.25M | 95.79% |
Cash from financing | -11.15M | -125.21% |
Net change in cash | 38.95M | 1,676.96% |
Free cash flow | 74.48M | 63.66% |
About
Founded
1933
Website
Employees
5,932